NEOPLASMS BY HISTOLOGIC TYPE
Clinical trials for NEOPLASMS BY HISTOLOGIC TYPE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY HISTOLOGIC TYPE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY HISTOLOGIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at Hard-to-Treat lymphomas
Disease control OngoingThis study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has come back or not responded to other therapies. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack cancer cells carrying a protein …
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
Could a cancer drug cut surgeries for rare throat condition?
Disease control OngoingThis study tests if bevacizumab, a drug that blocks blood vessel growth, can help adults with recurrent respiratory papillomatosis (RRP) go longer between surgeries. RRP causes wart-like growths in the airways that often return after removal. About 21 participants will receive th…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Robotic surgery vs. radiation: which is better for throat cancer patients' quality of life?
Symptom relief OngoingThis study compares two treatments for early-stage oropharyngeal (throat) cancer: robotic surgery or radiation therapy. The goal is to see which approach leads to better swallowing function and overall quality of life. About 138 patients will be randomly assigned to one of the tw…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC